COQ6
Basic information
Region (hg38): 14:73949926-73963670
Links
Phenotypes
GenCC
Source:
- familial steroid-resistant nephrotic syndrome with sensorineural deafness (Moderate), mode of inheritance: AR
- familial steroid-resistant nephrotic syndrome with sensorineural deafness (Supportive), mode of inheritance: AR
- familial steroid-resistant nephrotic syndrome with sensorineural deafness (Strong), mode of inheritance: AR
- SMARCB1-related schwannomatosis (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Coenzyme Q10 deficiency, primary 6 | AR | Biochemical | Some patients have been reported as showing a favorable response to oral Coenzyme Q supplementation | Biochemical; Musculoskeletal; Neurologic; Renal | 21540551 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Familial steroid-resistant nephrotic syndrome with sensorineural deafness (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COQ6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 52 | 54 | ||||
missense | 89 | 98 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 4 | 10 | 1 | 15 | ||
non coding | 10 | 40 | 33 | 83 | ||
Total | 11 | 8 | 102 | 94 | 40 |
Highest pathogenic variant AF is 0.0000132
Variants in COQ6
This is a list of pathogenic ClinVar variants found in the COQ6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-73949943-T-G | Benign (Jul 15, 2018) | |||
14-73949962-T-C | Benign (Jun 23, 2018) | |||
14-73949993-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
14-73949995-C-G | Benign (Jun 28, 2018) | |||
14-73950026-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
14-73950052-C-CAGTGACAGCGAT | not specified | Likely benign (Dec 21, 2015) | ||
14-73950062-G-T | not specified | Uncertain significance (Aug 17, 2021) | ||
14-73950073-C-T | not specified | Uncertain significance (May 04, 2022) | ||
14-73950079-T-G | not specified | Benign (Dec 09, 2013) | ||
14-73950095-G-A | not specified | Uncertain significance (May 24, 2023) | ||
14-73950113-C-G | not specified | Uncertain significance (Jan 08, 2024) | ||
14-73950129-G-T | not specified | Benign (Apr 23, 2014) | ||
14-73950133-G-A | not specified • Familial steroid-resistant nephrotic syndrome with sensorineural deafness • COQ6-related disorder | Benign (Jan 02, 2020) | ||
14-73950154-C-T | Likely benign (Mar 03, 2021) | |||
14-73950161-A-G | COQ6-related disorder | Likely benign (Dec 07, 2019) | ||
14-73950161-A-T | not specified | Uncertain significance (Apr 24, 2024) | ||
14-73950184-C-G | not specified | Uncertain significance (Nov 26, 2024) | ||
14-73950234-G-C | Benign (Jul 15, 2018) | |||
14-73950242-G-C | not specified | Benign (Jul 15, 2024) | ||
14-73950293-G-T | not specified | Benign (Dec 09, 2013) | ||
14-73950333-A-G | Familial steroid-resistant nephrotic syndrome with sensorineural deafness | Uncertain significance (Feb 07, 2024) | ||
14-73950337-C-A | Uncertain significance (Jun 15, 2022) | |||
14-73950337-C-T | Uncertain significance (Jun 04, 2022) | |||
14-73950339-G-A | Familial steroid-resistant nephrotic syndrome with sensorineural deafness | Uncertain significance (Mar 28, 2024) | ||
14-73950342-C-A | Likely benign (Sep 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COQ6 | protein_coding | protein_coding | ENST00000334571 | 12 | 13745 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.33e-15 | 0.0238 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.618 | 232 | 260 | 0.892 | 0.0000149 | 3041 |
Missense in Polyphen | 79 | 93.187 | 0.84776 | 1117 | ||
Synonymous | 1.25 | 89 | 105 | 0.845 | 0.00000673 | 952 |
Loss of Function | 0.286 | 23 | 24.5 | 0.938 | 0.00000135 | 270 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000231 | 0.000231 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000267 | 0.000264 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000751 | 0.000752 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: FAD-dependent monooxygenase required for the C5-ring hydroxylation during ubiquinone biosynthesis. Catalyzes the hydroxylation of 3-polyprenyl-4-hydroxybenzoic acid to 3- polyprenyl-4,5-dihydroxybenzoic acid. The electrons required for the hydroxylation reaction may be funneled indirectly from NADPH via a ferredoxin/ferredoxin reductase system to COQ6. {ECO:0000255|HAMAP-Rule:MF_03193}.;
- Disease
- DISEASE: Note=Mutations in COQ6 may play a role in susceptibility to Schwannomatosis, a cancer predisposition syndrome in which patients develop multiple non-vestibular schwannomas, benign neoplasms that arise from Schwann cells of the cranial, peripheral, and autonomic nerves. {ECO:0000269|PubMed:24763291}.;
- Pathway
- Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human);Ubiquinone Biosynthesis;Metabolism;Ubiquinol biosynthesis;Metabolism of cofactors;Metabolism of vitamins and cofactors;ubiquinol-10 biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.220
Intolerance Scores
- loftool
- 0.849
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.68
Haploinsufficiency Scores
- pHI
- 0.159
- hipred
- N
- hipred_score
- 0.248
- ghis
- 0.454
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.892
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | Medium |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Coq6
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype;
Zebrafish Information Network
- Gene name
- coq6
- Affected structure
- apoptotic process
- Phenotype tag
- abnormal
- Phenotype quality
- increased occurrence
Gene ontology
- Biological process
- ubiquinone biosynthetic process;oxidation-reduction process
- Cellular component
- mitochondrion;Golgi apparatus;extrinsic component of mitochondrial inner membrane;cell projection
- Molecular function
- protein binding;oxidoreductase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;FAD binding